法巴健康護理創新股票基金 I (歐元)

2022.78歐元3.54(0.18%)
2025/03/20更新
績效 / 
1月5.63%
3月0.04%
1年2.79%
晨星評等
資產分佈
  1. 1.現金2.76%
  2. 2.股票27.45%
  3. 3.債券0.00%
  4. 4.其他69.79%
前五大投資區域
  1. 1.美國69.79%
  2. 2.歐元區9.26%
  3. 3.英國7.65%
  4. 4.歐洲不包含歐元區7.28%
  5. 5.日本2.59%
前十大行業比重
  1. 1.健康護理97.24%
前十大持股
  1. 1.UnitedHealth Group Inc7.89%
  2. 2.AstraZeneca PLC6.90%
  3. 3.Eli Lilly and Co6.30%
  4. 4.Sanofi SA5.83%
  5. 5.Boston Scientific Corp4.99%
  6. 6.Thermo Fisher Scientific Inc4.45%
  7. 7.Intuitive Surgical Inc3.64%
  8. 8.Neurocrine Biosciences Inc3.39%
  9. 9.Vertex Pharmaceuticals Inc3.13%
  10. 10.Jazz Pharmaceuticals PLC3.11%
其他:包括其他持股、債券、現金與其他投資標的
資產分佈
  1. 1.現金2.76%
  2. 2.股票27.45%
  3. 3.債券0.00%
  4. 4.其他69.79%
前十大行業比重
  1. 1.健康護理97.24%
前五大投資區域
  1. 1.美國69.79%
  2. 2.歐元區9.26%
  3. 3.英國7.65%
  4. 4.歐洲不包含歐元區7.28%
  5. 5.日本2.59%
前十大持股
  1. 1.UnitedHealth Group Inc7.89%
  2. 2.AstraZeneca PLC6.90%
  3. 3.Eli Lilly and Co6.30%
  4. 4.Sanofi SA5.83%
  5. 5.Boston Scientific Corp4.99%
  6. 6.Thermo Fisher Scientific Inc4.45%
  7. 7.Intuitive Surgical Inc3.64%
  8. 8.Neurocrine Biosciences Inc3.39%
  9. 9.Vertex Pharmaceuticals Inc3.13%
  10. 10.Jazz Pharmaceuticals PLC3.11%
其他:包括其他持股、債券、現金與其他投資標的